For tumor characteristics, 23.86% cases were estrogen receptor negative (ER-), 19.89% had stage III tumors, 23.58% had poorly differentiated tumors, and 21.31% had large tumors (≥2 cm). The gene discussed is ESR1; the disease is neoplasm.